Agios Presents Updated Data from Phase 1 Dose-Escalation Study of AG-881 in Patients with IDH Mutant Positive Advanced Glioma
Bold Ventures Provides Update on Burchell Drilling Progress and Announces PDAC Participation at Booth #2610